VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company is headquartered in Cambridge, Massachusetts. Show more

160 SECOND STREET, CAMBRIDGE, MA, UNITED STATES, 02142, USA

BIOTECHNOLOGY
HEALTHCARE

Market Cap

1.873M

52 Wk Range

$0.00 - $0.00

Previous Close

$0.07

Open

$0.07

Volume

N/A

Day Range

$0.07 - $0.07

Enterprise Value

0.00

Cash

12.6M

Avg Qtr Burn

-11.77M

Insider Ownership

6.77%

Institutional Own.

13.04%

Qtr Updated

03/31/24


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
PreHevbrio (Sci-B-Vac®) Details
Hepatitis B, Hepatitis B vaccine, Pain

Approved

Quarterly sales

VBI-1901 (eVLP) Details
Glioblastoma, Cancer

Phase 2b

Data readout

VBI-2601 (BRII-179) combo w/ PEG-IFNα Details
Chronic hepatitis B, Hepatitis B

Phase 2

Update

Phase 1/2

Data readout

Phase 1/2

Update

Phase 1

Data readout

VBI-1501 Details
Cytomegalovirus

Phase 1

Update